Select Biosciences has announced that the RNAi/Screening Asia conference is to take place at the Matrix Building, Biopolis, in Singapore on 15-16 November 2010.
The agenda will include research from renowned speakers.
Speakers at RNAi Asia include: John Mattick, professor, University of Queensland; Alan Sachs, vice-president - RNA therapeutics, Merck Research Laboratories; Dan Peer, head - Laboratory of Nanomedicine, Tel Aviv University; and Shih-Peng Chan, assistant professor, National Taiwan University.
Speakers at Screening Asia include: Rathnam Chaguturu, director - high-throughput screening laboratories, University of Kansas; Paul Orange, business leader - biodiscovery, Perkin Elmer; Hakim Djaballah, director, Sloan-Kettering; and Sitta Sittampalam, professor, University of Kansas.
The full two-day agenda includes the following sessions in RNAi Asia: Target Discovery and Validation; Transfection; siRNA Therapeutics; In vivo RNAi; siRNA Library Screens; and microRNAs.
At Screening Asia, sessions include: High-Content Screening; Assay Development and Analysis; Novel Screening Platforms and Technologies; Screening and Drug Discovery; Biosimilars and Biologics; and Natural Products Screening.
